SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks Phase 3 DAYBREAK trial met its primary endpoints for Zenkuda and tabirafusp-ted in wet AMD, with Zenkudas extended dosing durability strengthening hopes for a planned FDA filing. The results fueled a sharp rally and short-squeeze chatter, while traders debated profit-taking, potential dilution, valuation, and the remaining FDA-approval risk.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp rally and heavy volume are driving attention, with traders pointing to IBM-related enterprise AI and digital-identity developments as a possible catalyst. Others attribute the move to a technical breakout, short covering, or broader crypto momentum, while questioning whether it can hold and noting uncertainty about a clear trigger.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants reported selection by The Clearing House for its on-chain money initiative is the dominant catalyst, with traders viewing it as a major institutional-adoption signal for the bank-focused interoperability network. Bulls cite limited token supply and potential demand, while skeptics question whether the deal creates meaningful demand for QNT itself; the sharp rally has also prompted profit-taking and volatility concerns.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares are under pressure after CEO Chirantan Desai departed for a senior role at Meta shortly before the companys investor day, raising concerns about leadership continuity despite reaffirmed guidance and former CEO Dev Ittycherias return as interim CEO. Traders are divided between viewing the selloff as an overreaction and buying opportunity and worrying that the abrupt transition signals uncertainty about strategy and execution.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Iran-related headlines about possible sanctions relief in exchange for nuclear concessions, plus anticipation of Trumps remarks, drove sharp SPY swings. Traders debated whether the reports signaled real progress or were unverified, while many dismissed the Iowa steel-plant announcement as unrelated to the markets main concerns.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius federal defense grant to convert a U.S. EV-battery line to high-energy-density drone cells is the main catalyst, drawing attention to domestic production expansion and potential defense demand. Traders are divided: bulls view the non-dilutive support as validation, while skeptics note it is not a purchase order and cite the long ramp to production as the stocks initial jump faded.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Positive wet-AMD updates from competitors Kodiak and 4D Molecular Therapeutics have pressured OCUL as traders reassess the competitive bar for AXPAXLI. Bulls argue AXPAXLI may offer stronger durability and a regulatory head start, while skeptics question its differentiation and market prospects.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Traders are linking CLFs sharp drop to the proposed Mesabi Metallics steel plant in Iowa, which some fear could compete with Cleveland-Cliffs or threaten its Minnesota leases. Others question the projects financing and feasibility and argue the selloff is driven by shorting rather than a fundamental threat.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTD is drawing attention amid a steep selloff and fresh multi-year lows, with traders linking the pressure to weak earnings guidance, slowing growth and S&P 500 removal-related selling. Sentiment is sharply divided between bearish criticism of management and competitive threats and dip buyers citing the companys cash generation and potential for a rebound; buyout and short-squeeze talk remains speculative.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ discussion is dominated by volatile trading around Trumps remarks and disputed reports of possible U.S.-Iran sanctions relief and nuclear concessions; the headlines sparked a relief rally, but many traders questioned the sourcing and whether a deal existed. That uncertainty is compounded by concern that rising Treasury yields and oil prices are pressuring tech stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mihalis

StockTwits for iOS

Capricor Therapeutics Inc

Attention centers on Capricors planned presentation of 24-month HOPE-3 extension data at the World Muscle Society Congress and the pending FDA review of deramiocel for Duchenne muscular dystrophy. Bulls hope the longer-term findings will strengthen the application, while skeptics question the trials statistical analysis and whether open-label data will address FDA concerns.